The small heat shock proteins, especially HspB4 and HspB5 are promising protectants in neurodegenerative diseases

Publication date: May 2018 Source:Neurochemistry International, Volume 115 Author(s): Zhihui Zhu, Georg Reiser Small heat shock proteins (sHsps) are a group of proteins with molecular mass between 12 and 43 kDa. Currently, 11 members of this family have been classified, namely HspB1 to HspB11. HspB1, HspB2, HspB5, HspB6, HspB7, and HspB8, which are expressed in brain have been observed to be related to the pathology of neurodegenerative diseases, including Parkinson's, Alzheimer's, Alexander's disease, multiple sclerosis, and human immunodeficiency virus-associated dementia. Specifically, sHsps interact with misfolding and damaging protein aggregates, like Glial fibrillary acidic protein in AxD, β-amyloid peptides aggregates in Alzheimer's disease, Superoxide dismutase 1 in Amyotrophic lateral sclerosis and cytosine-adenine-guanine/polyglutamine (CAG/PolyQ) in Huntington's disease, Spinocerebellar ataxia type 3, Spinal-bulbar muscular atrophy, to reduce the toxicity or increase the clearance of these protein aggregates. The degree of HspB4 expression in brain is still debated. For neuroprotective mechanisms, sHsps attenuate mitochondrial dysfunctions, reduce accumulation of misfolded proteins, block oxidative/nitrosative stress, and minimize neuronal apoptosis and neuroinflammation, which are molecular mechanisms commonly accepted to mirror the progression and development of neurodegenerative diseases. The increasing incidence of the neurodegenerative diseases enhance...
Source: Neurochemistry International - Category: Neuroscience Source Type: research

Related Links:

After his grandmother was hospitalised, Lewis invented a hydrating treat for people with dementia.
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
Publication date: October 2018Source: The Lancet Neurology, Volume 17, Issue 10Author(s): Brian J Balin, Alan P Hudson
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: October 2018Source: The Lancet Neurology, Volume 17, Issue 10Author(s): Maria A Rocca, Frederik Barkhof, John De Luca, Jonas Frisén, Jeroen J G Geurts, Hanneke E Hulst, Jaume Sastre-Garriga, Massimo Filippi, Frederik Barkhof, Olga Ciccarelli, Nicola De Stefano, Christian Enzinger, Massimo Filippi, Jette L. Frederiksen, Claudio Gasperini, Ludwig Kappos, Jacqueline Palace, Maria A. Rocca, Alex Rovira, Jaume Sastre-GarrigaSummarySome of the clinical manifestations of multiple sclerosis, such as memory impairment and depression, are, at least partly, related to involvement of the hippocampus. Pathologi...
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: October 2018Source: The Lancet Neurology, Volume 17, Issue 10Author(s): Miguel Leal Rato, Gonçalo S Duarte, Tiago Mestre, Mamede de Carvalho, Joaquim J Ferreira
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: October 2018Source: The Lancet Neurology, Volume 17, Issue 10Author(s): Anthony Feinstein
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: October 2018Source: The Lancet Neurology, Volume 17, Issue 10Author(s): Peter K Stys
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: October 2018Source: The Lancet Neurology, Volume 17, Issue 10Author(s): Nicholas D James, Stephen B McMahon, Edelle C Field-Fote, Elizabeth J BradburySummaryNeuromodulation, the use of electrical interfaces to alter neuronal activity, has been successful as a treatment approach in several neurological disorders, including deep brain stimulation for Parkinson's disease and epidural spinal stimulation for chronic pain. Neuromodulation can also be beneficial for spinal cord injury, from assisting basic functions such as respiratory pacing and bladder control, through to restoring volitional movements and ski...
Source: The Lancet Neurology - Category: Neurology Source Type: research
Publication date: Available online 18 September 2018Source: PhytomedicineAuthor(s): Yingying Jiang, Hongwei GaoABSTRACTBackgroundAlzheimer's disease is a severe neurodegenerative disease of the central nervous system in the elderly.Hypothesis/PurposeIn our study, we aimed to find the best potential small molecule for AD treatment.Study designWe used many models in Discovery Studio 2016 to find new potential inhibitors of butyrylcholinesterase (BChE), including pharmacophore model, virtual screening model, molecular docking model, de novo evolution model.MethodsLigand-based pharmacophore models were used to identify the cri...
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research
In this study, we aimed to investigate the mitochondrial mechanisms involved in the neuroprotection of PQQ both in vitro and in vivo. The cultured human SH-SY5Y neuroblastoma cells were exposed to different concentrations of PQQ after which the cells were treated with rotenone. Electron microscopy images showed that PQQ could prevent the mitochondrial morphology damage. The down-regulation of mitochondrial biogenesis related genes (PGC-1alpha and TFAM) and mitochondrial fission and fusion related genes (Drp1and Mfn2) in rotenone-injured SH-SY5Y cells could be inhibited by PQQ. PQQ could also promote the transposition of Dr...
Source: Neuroscience Letters - Category: Neuroscience Source Type: research
Publication date: Available online 18 September 2018Source: NeuroImageAuthor(s): Lorenzo Massimi, Inna Bukreeva, Giulia Santamaria, Michela Fratini, Alessandro Corbelli, Francesco Brun, Stefano Fumagalli, Laura Maugeri, Alexandra Pacureanu, Peter Cloetens, Nicola Pieroni, Fabio Fiordaliso, Gianluigi Forloni, Antonio Uccelli, Nicole Kerlero de Rosbo, Claudia Balducci, Alessia CedolaAbstractAlzheimer's disease (AD), the most common form of dementia, is a progressive neurodegenerative disorder associated with aberrant production of beta-amyloid (Aβ) peptide depositing in brain as amyloid plaques. While animal models allo...
Source: NeuroImage - Category: Neuroscience Source Type: research
More News: ALS | Alzheimer's | Ataxia | Autoimmune Disease | Brain | Dementia | Huntington's Disease | Mitochondrial Disease | Multiple Sclerosis | Neurology | Neuroscience | Parkinson's Disease | Pathology | Toxicology